JohnContiMD

PubMed

• 19 citations
  Non-Melanoma Skin Cancers in the Older Patient.
  Ashley Albert, Miriam A. Knoll, John A. Conti, Ross I S Zbar
  Current Oncology Reports. 2019-07-29
• 8 citations
  A Rare Case of Grey Zone Lymphoma Successfully Treated with Brentuximab Vedotin and R-CHP Chemotherapy
  Rajiv M. Mallipudi, Lance Alquran, Vishnu A. Shenoy, Lori A. Leslie, John A. Conti
  Case Reports in Oncological Medicine. 2019-04-11
• 642 citations
  Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer
  Nancy E. Kemeny, Ying Huang, Alfred M. Cohen, Weiji Shi, John A. Conti
  The New England Journal of Medicine. 1999-12-30

Journal Articles

• Hepatio Arterial Infusion of Chemotherapy after Resection of Hepatic Metastases from Colorectal Cancer.  
  Kemeny N, Huang Y, Cohen AM, Shi W, Conti JA, et al, N Engl J Med, 1/1/1999
• Site Specific Study: Breast Cancer -DCIS.  
  Conti JA, Arani I, Mountainside Hospital Cancer Program Annual Report, 1/1/1998
• Phase II Trial of Docetaxel (Taxotere) for Untreated Advanced Colorectal Carcinoma.  
  Clark TB, Kemeny NE, Conti JA, et al, Cancer Invest, 1/1/1998
• Preoperative 5-FU, Low-Dose Leucovorin, and Radiation Therapy for Locally Advanced and Unresectable Rectal Cancer.  
  Minsky BD, Cohen AM, Enker WE, Conti J, Int J Radiat Oncol Biol Phys, 1/1/1997
• Acute Toxicity of Neoadjuvant Bolus 5-FU and Followed by Continuous Infusion 5-FU Plus Pre-Operative Radiaition Therapy for Rectal Cancer.  
  Minsky B, Conti J, Cohen A, Kelsen D, et al, Radiat Oncol Invest, 1/1/1996
• Irinotecan (CPT-11) is an Active Agent in Untreated Patients with Metastatic Colorectal Cancer.  
  Conti JA, Kemeny NE, Saltz LB, Hunag Y, et al, J Clin Oncol, 1/1/1996
• A Comparison of Umbilical Cord Blood Gas Values betwen Newborns with and without True Knots.  
  Maher JT, Conti JA, Hawkes GG, Obstet Gynecol, 1/1/1995
• Relationship of Acute Gastrointestinal Toxicity and the Volume of Irradiated Small Bowel in Patients Receiving Combined Modality Therpay for Rectal Cancer.  
  Minsky B, Conti J, Huang Y, Knoph K, J Clin Oncol, 1/1/1995
• A Fixed-Ratio Combination of Uracil and Ftorafur(UFT) and Low Dose Leucovorin: An Active Oral Regimen for Advanced Colorectal Cancer.  
  Saltz L, Leichman CG, Young CW, Muggia FM, Conti JA, et al, Cancer, 1/1/1995
• Continuous Infusion Fluorouracil/Leucovorin and Bolus Mitomycin-C as a Salvage Regimen in Advanced Colorectal Cancer.  
  Conti JA, Kemeny N, Saltz L, et al, Cancer, 1/1/1995
• Cancer chemotherapy in the elderly.  
  Conti JA, Christman K, J Clin Gastroenterol, 1/1/1995
• Trial of Sequential Trimetrexate, Fluorouracil and High-Dose Leucovorin in Previously Treated Patients with Gastrointestinal Carcinoma.  
  Conti JA, Kemeny N, Seiter K, et al, J Clin Oncol, 1/1/1994
• Chemotherapy for Colorectal Cancer.  
  Kemeny NE, Conti JA, Bertino JR, N Engl J Med, 1/1/1994
• A Phase II Study of Hepatic Arterial FUDR, Leucovorin, and Dexamethasone for Unresectable Liver Metastases from Colorectal Carcinoma.  
  Kemeny N, Conti JA, Cohen A, et al, J Clin Oncol, 1/1/1994
• Commentary on - "Chemoembolization of Hepatic Malignancies".  
  Conti JA, Kemeny N, Oncology, 1/1/1994
• Hepatic Arterial FUDR and Leucovorin for Unresectable Liver Metastases from Colorectal Carcinoma: New Dose Schedules and Survival Update.  
  Kemeny N, Seiter K, Conti JA, et al, Cancer, 1/1/1994
• Pre-operative 5-Fluorouracil, low dose leucovorin, and concurrent radiation therapy for rectal cancer.  
  Minsky B, Cohen A, Enker W, Conti J, Cancer, 1/1/1994
• Hereditary spherocytosis and hematologic malignancy.  
  Conti JA, Howard LM, NJ Med, 1/1/1994
• Colon carcinoma metastatic to the trachea: Report of a case and a review of the literature.  
  Conti JA, Kemeny N, Klimstra D, Am J Clin Oncol, 1/1/1994
• A randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colore...  
  Kemeny N, Conti JA, Sigurdson E, et al, J Clin Oncol, 1/1/1993
• A pilot study of hepatic artery floxuridine combined with systemic 5-fluorouracil and leucovorin: A potential adjuvant program after resection of colorectal hepatic me...  
  Kemeny N, Conti JA, Sigurdson E, et al, Cancer, 1/1/1993
• Acute arterial thrombosis after escalated dose methotrexate, vinblastine, doxorubicin and cisplatin (M-VAC) chemotherapy with recombinant granulocyte colony-stimulatin...  
  Conti JA, Scher HI, Cancer, 1/1/1992
• Biochemical modulation of bolus fluorouracil by PALA in patients with advanced colorectal cancer.  
  Kemeny N, Conti JA, Seiter K, et al, J Clin Oncol, 1/1/1992
• Case Report: Type la glycogenosis associated with hepatocellular carcinoma.  
  Conti JA, Kemeny N, Cancer, 1/1/1992
• Seventeen ways to help you survive your residency.  
  Conti JA, Residents' Forum in Internal Medicine, 11/1/1990
• Join now to see all

Books/Book Chapters

• Cancer of the Colon, Rectum, and Anus 
  Chapter: Metastatic Colorectal Cancer: Are There Prognostic Determinants. 
  Page 769 - 781Conti JA, Kemeny NEditors: Cohen AM, Winawer SJ.McGraw-Hill, Inc., New York, NY.1995

Abstracts/Posters

• Treatment with Gemcitabine (GEM) for Patients with Advanced Pancreatic Cancer in a Community Oncology Practice.
  Conti JA, Scoppetuolo M, Alter RS, et al, Clinical Cancer Research in NJ, 3/5/1997
• Final Results of a Phase I Trial of Sequential Trimetrexate (TMTX), Fluorouracil (FU), and High Dose Leucovorin (LV) in Previously Treated Patients (Pts) with Gastroin...
  Conti JA, Kemeny NE, Tong W, Andre M, Bertino JR, Proc Am Soc Clin Oncol, 1/1/1997
• Phase I Trial of Irinotecan (CPT-11), 5-Fluorouracil (FU), and Leucovorin (LV) in Patients with Advanced Solid Tumors.
  Saltz L, Kanowitz J, Kemeny N, Kelsen D, Conti J, et al, Proc Am Soc Clin Oncol, 1/1/1995
• Molecular Radiotherapy of Hepatic Metastases from Colorectal Cancer (CA) using Hepatic Arterial I-131/I-125-Iododeoxyuridine (IUdR).
  Macapinlac H, Kemeny N, Daghighian F, Conti J, et al, Proc Am Soc Clin Oncol, 1/1/1995
• Hepatic Arterial Infusion of Floxuridine (FUDR), Dexamethasone (Dex) and High Dose Mitomycin C (Mit C): Comparable Response to FUDR/ Leucovorin/Dex but with Greater To...
  Kemeny N, Conti JA, Blumgart L, et al, Proc Am Soc Clin Oncol, 1/1/1995
• Relationship of Acute Gastrointestinal Toxicity and the Volume of Irradiated Small Bowel in Patients Receiving Combined Modality Therpay for Rectal Cancer.
  Minsky B, Conti J, Huang Y, Knoph K, Proc Am Soc Clin Oncol, 1/1/1995
• Triacetyluridine(TAU) as Rescue for 5-Fluorouracil (FU) Allows Increased FU Dose Intensity When Given with N-Phosphonacetyl-L-Aspartate (PALA) and Methotrexate (MTX) i...
  Conti JA, Kemeny N, Kelly J, Gonzalez C, Bertino J, Martin D, Proc Am Soc Clin Oncol, 1/1/1995
• Experience with Trimetrexate in GI Cancer.
  Conti JA, J Clin Invest Chemotherapy, 1/1/1995
• Combined Modality Therapy of Rectal Cancer: Past Results and Future Directions.
  Conti JA, Kemeny N, Minsky BD, J Infus Chemo, 1/1/1994
• Phase ll Trial of Docetaxel (Taxotere, RP56976) in Previously Untreated Patients (pts) with Advanced Colorectal Cancer (CRC).
  Clark T, Kemeny N, Conti JA, Andre M, Proc Am Soc Clin Oncol, 1/1/1994
• Irinotecan (CPT-11) is an active agent in untreated patients (pts) with metastatic colorectal cancer (CRC).
  Conti JA, Kemeny N, Saltz L, Tong W, Chou TC, Pulliam M, et al, Proc Am Soc Clin Oncol, 1/1/1994
• Phase l and clinical pharmacologic studies of oral UFT alone and with oral leucovorin.
  Saltz L, Young C, Currie V, Tong W, Conti J, et al, Proc Am Soc Clin Oncol, 1/1/1993
• Pre-operative 5-FU, low dose leucovorin, and concurrent radiation therapy for rectal cancer.
  Minsky B, Cohen A, Enker W, Conti J, Proc Am Soc Clin Oncol, 1/1/1993
• Long term survival in patients with hepatic metastases from colorectal cancer treated with continuous intrahepatic infusion of floxuridine and leucovorin via an infusa...
  Kemeny N, Conti JA, Seiter K, et al, Proc Am Soc Clin Oncol, 1/1/1993
• A phase l trial of sequential trimetrexate, fluorouracil and high-dose leucovorin in previously treated patients with gastrointestinal carcinoma.
  Conti JA, Kemeny N, Goker E, et al, Proc Am Soc Clin Oncol, 1/1/1993
• Continuous infusion fluorouracil/leucovorin and bolus mitomycin-C as a salvage regimen in advanced colorectal carcinoma.
  Conti JA, Kemeny N, Bertino J, et al, Proc Am Soc Clin Res, 1/1/1993
• A Phase I trial of hepatic artery fluorodeoxyuridine (FUDR) with systemic 5-fluorouracil (FU) and leucovorin (LV) as adjuvant therapy after colorectal carcinoma hepati...
  Kemeny N, Conti JA, Seiter K, et al, Proc Am Soc Clin Oncol, 1/1/1992
• A Phase I-II trial of Phosphonacetyl-L-Aspartic Acid (PALA) and 5-fluorouracil (FU) in metastatic colorectal carcinoma with oral uridine (UR) as a rescue agent for FU.
  Kemeny N, Conti JA, Martin D, et al, Proc Am Soc Clin Oncol, 1/1/1992
• Join now to see all